Foralumab stabilized disability for 6 months in all 10 people with nonactive SPMS who took part in an expanded access program, a study found.

Dissolvable film BNT23001 led to about 40% higher cladribine exposure than tablets in a preclinical pig study, BioNxt ...

Brenig has launched an early Phase 1 trial to evaluate BT-409, its experimental small molecule therapy, in healthy volunteers ...

A brain protein called ANO2 has emerged as a new piece of the puzzle linking Epstein-Barr virus (EBV) infections and MS ...

People whose biological mothers had diabetes during pregnancy are more likely to develop MS as adults, according to a study ...

Telling yourself you're doing the best with what you have is one of many examples of compassionate self-care, writes ...

The Swoop portable MRI system showed 92% agreement with traditional MRI scans and was four times more likely to be chosen by ...

January might offer a new year reset, but chronic illness demands us to move forward and bring what we’ve learned, says ...

The Epstein-Barr virus and a high-risk gene may work together to trick the immune system into attacking the brain in MS, a ...

Paralyzed Veterans of America has launched a free, online, adaptive fitness and wellness program for vets with MS, ALS, and ...

Machine learning can help predict whether people newly diagnosed with MS will experience disability worsening that occurs ...

MS has a way of making everything feel interconnected, writes columnist Desiree Lama, and that includes her relationship with ...